Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1

Y Ye, X Kuang, Z Xie, L Liang, Z Zhang, Y Zhang… - Genome medicine, 2020 - Springer
Background Immune checkpoint blockade (ICB) therapy has demonstrated considerable
clinical benefit in several malignancies, but has shown favorable response in only a small
proportion of cancer patients. Recent studies have shown that matrix metalloproteinases
(MMPs) are highly associated with the microenvironment of tumors and immune cells.
However, it is unknown whether MMPs are involved in immunotherapy. Methods Here, we
used integrative analysis to explore the expression landscape of the MMP family and its …

[引用][C] Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1. Genome Med. 2020; 12 (1): 83

Y Ye, X Kuang, Z Xie, L Liang, Z Zhang, Y Zhang, F Ma… - Epub 2020/09/30. https://doi. org …
以上显示的是最相近的搜索结果。 查看全部搜索结果